메뉴 건너뛰기




Volumn 25, Issue 2, 2013, Pages

Aripiprazole treatment for choreoathetoid and psychotic symptoms of Huntington's disease

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; CLONAZEPAM; QUETIAPINE;

EID: 84883288112     PISSN: 08950172     EISSN: 15457222     Source Type: Journal    
DOI: 10.1176/appi.neuropsych.12040097     Document Type: Letter
Times cited : (9)

References (4)
  • 1
    • 33846225133 scopus 로고    scopus 로고
    • Huntington's disease
    • Walker FO: Huntington's disease. Lancet 2007; 369:218-228
    • (2007) Lancet , vol.369 , pp. 218-228
    • Walker, F.O.1
  • 2
    • 54049089271 scopus 로고    scopus 로고
    • Dopaminergic and glutamatergic signaling crosstalk in Huntington's disease neurodegeneration: The role of p25/cyclin-dependent kinase 5
    • Paoletti P, Vila I, Rifé M, et al: Dopaminergic and glutamatergic signaling crosstalk in Huntington's disease neurodegeneration: the role of p25/cyclin-dependent kinase 5. J Neurosci 2008; 28:10090-10101
    • (2008) J Neurosci , vol.28 , pp. 10090-10101
    • Paoletti, P.1    Vila, I.2    Rifé, M.3
  • 3
    • 34047180648 scopus 로고    scopus 로고
    • The corticostriatal pathway in Huntington's disease
    • Cepeda C, Wu N, André VM, et al: The corticostriatal pathway in Huntington's disease. Prog Neurobiol 2007; 81:253-271
    • (2007) Prog Neurobiol , vol.81 , pp. 253-271
    • Cepeda, C.1    Wu, N.2    André, V.M.3
  • 4
    • 9944225707 scopus 로고    scopus 로고
    • Aripiprazole: A new atypical antipsychotic with a different pharmacological mechanism
    • Naber D, Lambert M: Aripiprazole: a new atypical antipsychotic with a different pharmacological mechanism. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28:1213-1219
    • (2004) Prog Neuropsychopharmacol Biol Psychiatry , vol.28 , pp. 1213-1219
    • Naber, D.1    Lambert, M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.